Citation

Londregan AT, Wei L, Xiao J, Lintner NG, Petersen D, Dullea RG, McClure KF, Bolt MW, Warmus JS, Coffey SB, Limberakis C, Genovino J, Thuma BA, Hesp KD, Aspnes GE, Reidich B, Salatto CT, Chabot JR, Cate JHD, Liras S, Piotrowski DW.: Small Molecule Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Hit to Lead Optimization of Systemic Agents. J Med Chem, Volume 61 (13), 2018

Authors

Aspnes GE, Bolt MW, Cate JHD, Chabot JR, Coffey SB, Dullea RG, Genovino J, Hesp KD, Limberakis C, Lintner NG, Liras S, Londregan AT, McClure KF, Petersen D, Piotrowski DW., Reidich B, Salatto CT, Thuma BA, Warmus JS, Wei L, Xiao J

Journal

J Med Chem

Year

2018

DOI

10.1021/acs.jmedchem.8b00650

PubMed

29878763

Machine-readable

REST APIRDF